Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

6.36

-0.08 (-1.24%)

Sep 12, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
Transformative Cell and Exosome-based Therapeutics	22.27M	Log In	Log In	Log In	Log In	Upgrade
Transformative Cell and Exosome-based Therapeutics Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
United States	22.27M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade